author-photo

Takazumi Taniguchi

SANTEN PHARMACEUTICAL CO., LTD.

27

Papers

422

Citations

Citation Trend

Filter By

Papers (27) Sort By

Journal Conference Others

Additive Intraocular Pressure-Lowering Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, Combined with Existing Antiglaucoma Agents in Conscious Ocular Normotensive Monkeys.

2021 Journal of Ocular Pharmacology and Therapeutics
Show All
- Source
- Cite
- Save
Citations (1)
Novel use of a chemically modified siRNA for robust and sustainable in vivo gene silencing in the retina.

2020 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (2)
Efficacy and safety of the fixed combinations of tafluprost/timolol and latanoprost/carteolol

2019 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (3)
Effects of Omidenepag Isopropyl, a Selective EP2 Receptor Agonist, on Iris Pigmentation

2019 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Effects of Omidenepag, a Selective EP2 Receptor Agonist on Adipocyte Differentiation

2019 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (1)
Effects of a selective EP2 receptor agonist, omidenepag isopropyl, on eyelash growth in mice

2018 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (1)
Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-induced Ocular Hypertensive Monkeys

2018 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (0)
Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent

2018 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (37)
Effects of a Novel Selective EP2 Receptor Agonist, Omidenepag Isopropyl, on Aqueous Humor Dynamics in Laser-Induced Ocular Hypertensive Monkeys

2018 Journal of Ocular Pharmacology and Therapeutics
Show All
- Source
- Cite
- Save
Citations (32)
Omidenepag isopropyl, a selective EP2 agonist, shows additive intraocular pressure (IOP)-lowering effects when used concomitantly with existing anti-glaucoma drugs in animal models

2017 Investigative Ophthalmology & Visual Science
Show All
- Source
- Cite
- Save
Citations (1)